Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 162.10
-1.45 (-0.89%)
At close: May 5, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 7.83 billion as of May 6, 2026. Its market cap has decreased by -18.75% in one year.
Market Cap
7.83B
Enterprise Value
9.02B
Revenue
6.20B
Ranking
n/a
PE Ratio
47.46
Stock Price
162.10
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 7.83B, an increase of 1,268.37%. That is a compound annual growth rate of 11.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 7.93B | 9.57% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lincoln Pharmaceuticals | 12.93B |
| Syncom Formulations (India) | 12.91B |
| TTK Healthcare | 12.82B |
| Shukra Pharmaceuticals | 12.73B |
| Fredun Pharmaceuticals | 12.30B |
| Fermenta Biotech | 9.16B |
| Wanbury | 9.00B |
| Bharat Parenterals | 8.33B |